COVID-19 pandemic: what about the safety of anti-coronavirus nanoparticles?

DA Mosselhy, J Virtanen, R Kant, W He, M Elbahri… - Nanomaterials, 2021 - mdpi.com
Every day, new information is presented with respect to how to best combat the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). This manuscript sheds light on such …

Repurposing immune boosting and anti-viral efficacy of Parkia bioactive entities as multi-target directed therapeutic approach for SARS-CoV-2: exploration of lead …

R Dinata, N Nisa, C Arati, B Rasmita… - Journal of …, 2024 - Taylor & Francis
The COVID-19 pandemic has caused adverse health (severe respiratory, enteric and
systemic infections) and environmental impacts that have threatened public health and the …

Infection of SARS-CoV-2 in domestic dogs associated with owner viral load

AB de Souza Barbosa, LB Kmetiuk… - Research in Veterinary …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive pet owners are
reported to be a risk factor for infection of their pets; however, the influence of the viral load …

Investigation of SARS-CoV-2 infection and associated lesions in exotic and companion animals

DS Rotstein, S Peloquin, K Proia, E Hart… - Veterinary …, 2022 - journals.sagepub.com
Documented natural infections with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in exotic and companion animals following human exposures are uncommon. Those …

Investigation of the role of healthy and sick equids in the COVID-19 pandemic through serological and molecular testing

KOY Lawton, RM Arthur, BC Moeller, S Barnum… - Animals, 2022 - mdpi.com
Simple Summary The objective of the present study was to determine if horses are
susceptible to SARS-CoV-2. Nasal swabs from 667 equids with acute onset of fever and …

[HTML][HTML] Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera‐hosted coronaviruses: SARS‐CoV, MERS‐CoV …

DJ Machado, R Scott, S Guirales, DA Janies - Cladistics, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus (SARS‐CoV) emerged in humans in
2002. Despite reports showing Chiroptera as the original animal reservoir of SARS‐CoV …

[HTML][HTML] Interactions between humans and dogs during the COVID-19 pandemic: recent updates and future perspectives

MS Kamel, AA El-Sayed, RA Munds, MS Verma - Animals, 2023 - mdpi.com
COVID-19 is one of the deadliest epidemics. This pandemic is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), but the role of dogs in spreading the …

[HTML][HTML] Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines

AS Abdel-Moneim, EM Abdelwhab, ZA Memish - Virology, 2021 - Elsevier
SARS-CoV-2 is a novel coronavirus, spread among humans, and to date, more than 100
million of laboratory-confirmed cases have been reported worldwide. The virus …

Limited cross‐species transmission and absence of mutations associated with SARS‐CoV‐2 adaptation in cats: A case study of infection in a small household setting

SC Chaintoutis, VI Siarkou… - Transboundary and …, 2022 - Wiley Online Library
In the present study, the course of SARS‐CoV‐2 natural infection in two asymptomatic cats,
which were negative for immunosuppressive retroviral infections, is investigated. The source …

Central role of lung macrophages in SARS-CoV-2 physiopathology: a cross-model single-cell RNA-seq perspective

T Olivier, J Blomet, D Desmecht - Frontiers in Immunology, 2023 - frontiersin.org
Cytokine storms are considered a driving factor in coronavirus disease 2019 (COVID-19)
severity. However, the triggering and resolution of this cytokine production, as well as the …